https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47173 Wed 14 Dec 2022 15:56:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20369 Wed 10 Jul 2019 15:20:28 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34461 Wed 04 Sep 2019 09:49:32 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:577 Thu 25 Jul 2013 09:10:28 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:550 Thu 25 Jul 2013 09:10:25 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39270 Thu 02 Jun 2022 14:37:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7611 60 years. The prevalence was about double using the Cockcroft-Gault equations, i.e. 7.5% (95% CI: 6.9 – 8.2%) and 34.9 (95% CI: 25.9 – 44.8%) in age ≤ 50 and > 50 years, respectively. The prevalence was similar in Caucasians and Asians aged ≤ 60, i.e. 9.9 versus 9.3%. The prevalence was also higher in the diabetic population than in the general population, i.e. 18.2% versus 10.6%. The pooled prevalence of CKD in the general population varied according to age groups. The prevalence is similar in Caucasians and Asians within age 60 years or younger but other age groups need more studies in order to pool. Individual patient meta-analysis would be appropriate to resolve the causes of heterogeneity.]]> Sat 24 Mar 2018 08:34:41 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21578 Sat 24 Mar 2018 08:00:43 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18956 Sat 24 Mar 2018 07:58:57 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18943 Sat 24 Mar 2018 07:58:52 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20365 Sat 24 Mar 2018 07:58:11 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17993 24 h of life. Data sources: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, CINAHL, Cochrane Library, clinicaltrials.gov, controlled-trials.com, American Pediatric and European Paediatric Research Societies and Effective Care of the Newborn Infant. Review methods: ystematic review with network meta-analysis of randomised studies comparing intravenous indomethacin, ibuprofen or placebo for PDA in preterm infants at >24 h of life. Results: ten trials compared intravenous indomethacin versus intravenous ibuprofen, nine intravenous indomethacin versus placebo and one intravenous ibuprofen versus placebo. Both intravenous indomethacin (pooled RR 2.39 (95% CI 2.05 to 2.78)) and intravenous ibuprofen (RR 2.40 (95% CI 2.03 to 2.84)) closed a PDA more effectively than placebo. Intravenous ibuprofen was associated with approximately 30% greater risk of chronic lung disease than intravenous indomethacin (RR 1.28 (95% CI 1.03 to 1.60)) or placebo (RR 1.29 (95% CI 0.99 to 1.70)). Differences in risk or benefit were not significant between any combination of intravenous indomethacin, intravenous ibuprofen or placebo groups for intraventricular haemorrhage, necrotising enterocolitis and death. Reporting on neurological outcomes was insufficient for pooling. Conclusions: intravenous indomethacin or ibuprofen administered to preterm infants for PDA at >24 h of life promoted ductal closure, but other short-term benefits were not seen. Treatment with intravenous ibuprofen may increase the risk of chronic lung disease. Good-quality evidence of treatment effect on morbidity, mortality and improved neurodevelopment is urgently needed.]]> Sat 24 Mar 2018 07:56:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4620 Sat 24 Mar 2018 07:21:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4787 Sat 24 Mar 2018 07:20:44 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4856 Sat 24 Mar 2018 07:18:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22553 Sat 24 Mar 2018 07:14:44 AEDT ]]>